Correlation Between Enliven Therapeutics and Black Diamond

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Black Diamond Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Black Diamond.

Diversification Opportunities for Enliven Therapeutics and Black Diamond

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Enliven and Black is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Black Diamond go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Black Diamond

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 2.63 times less return on investment than Black Diamond. But when comparing it to its historical volatility, Enliven Therapeutics is 2.54 times less risky than Black Diamond. It trades about 0.04 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  157.00  in Black Diamond Therapeutics on September 1, 2024 and sell it today you would earn a total of  108.00  from holding Black Diamond Therapeutics or generate 68.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  Black Diamond Therapeutics

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Enliven Therapeutics and Black Diamond Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and Black Diamond

The main advantage of trading using opposite Enliven Therapeutics and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.
The idea behind Enliven Therapeutics and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites